Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenomedullin activity in chronically hypoxic rat lungs

L Zhao1, L A Brown, A A Owji

  • 1Department of Clinical Pharmacology, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.

The American Journal of Physiology
|August 1, 1996
PubMed
Summary

Adrenomedullin (AM) effectively lowers pulmonary artery pressure in rats with hypoxia-induced pulmonary hypertension. This response is partly mediated by calcitonin gene-related peptide (CGRP) receptors, suggesting AM

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells.

Science advances·2021
Same author

Effect of quercetin on the brain-derived neurotrophic factor gene expression in the rat brain.

Bratislavske lekarske listy·2018
Same author

The effect of intra-cerebroventricular injection of insulin on nociception of formalin test in non-diabetic and short-term diabetic rat models.

Iranian journal of veterinary research·2017
Same author

Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro.

Journal of endocrinological investigation·2016
Same author

Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin.

Diabetes, obesity & metabolism·2016
Same author

Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?

Diabetes, obesity & metabolism·2016

Area of Science:

  • Cardiovascular Physiology
  • Pulmonary Hypertension Research
  • Pharmacology

Background:

  • Adrenomedullin (AM) is a vasodilator structurally related to calcitonin gene-related peptide (CGRP).
  • Hypoxia-induced pulmonary hypertension is a significant clinical condition.
  • Understanding novel vasodilators' roles in pulmonary hypertension is crucial.

Purpose of the Study:

  • To investigate the activity of Adrenomedullin (AM) in the rat lung during hypoxia-induced pulmonary hypertension.
  • To explore the relationship between AM and CGRP pathways in regulating pulmonary artery pressure.
  • To assess the potential of AM as a therapeutic agent.

Main Methods:

  • Isolated perfused rat lung model ventilated with 2% oxygen.
  • Administration of varying doses of rat AM and alpha-CGRP.

Related Experiment Videos

  • Pretreatment with alpha-CGRP or CGRP antagonist (CGRP-(8-37)).
  • Measurement of pulmonary artery pressure.
  • Radioligand binding assays using 125I-labeled AM and 125I-labeled CGRP.
  • Quantification of lung immunoreactive AM and AM mRNA levels.
  • Main Results:

    • Both AM and alpha-CGRP dose-dependently reduced pulmonary artery pressure.
    • AM's hypotensive effect was partially attenuated by alpha-CGRP or CGRP antagonist, indicating CGRP receptor involvement.
    • 125I-labeled AM and CGRP binding increased significantly in lung membranes of hypoxic rats.
    • Hypoxic rats showed an enhanced hypotensive response to both AM and CGRP.
    • No significant changes were observed in lung immunoreactive AM concentrations or AM mRNA levels.

    Conclusions:

    • Adrenomedullin (AM) demonstrates significant vasodilatory activity in the context of hypoxia-induced pulmonary hypertension.
    • The response to AM is partly mediated through calcitonin gene-related peptide (CGRP) receptors.
    • AM shows potential for acute pharmacological management of pulmonary artery pressure in this condition.